Aytu Biopharma, Inc.
AYTU
$2.18
$0.010.46%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.56M | 1.64M | -5.24M | -6.25M | -15.84M |
| Total Depreciation and Amortization | 5.38M | 5.64M | 5.86M | 6.31M | 6.73M |
| Total Amortization of Deferred Charges | 108.00K | 216.00K | 350.00K | 476.00K | 597.00K |
| Total Other Non-Cash Items | 12.14M | -3.89M | -3.04M | 2.14M | 13.86M |
| Change in Net Operating Assets | -6.00M | -9.14M | 2.75M | -5.05M | -6.73M |
| Cash from Operations | -1.94M | -5.53M | 673.00K | -2.37M | -1.39M |
| Capital Expenditure | -228.00K | -540.00K | -471.00K | -465.00K | -329.00K |
| Sale of Property, Plant, and Equipment | 668.00K | 668.00K | 668.00K | 517.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.00M | 295.00K | 250.00K | 76.00K | 0.00 |
| Cash from Investing | -2.56M | 423.00K | 447.00K | 128.00K | -329.00K |
| Total Debt Issued | 8.53M | 21.45M | 15.45M | 15.71M | 13.83M |
| Total Debt Repaid | -1.86M | -17.05M | -16.07M | -15.82M | -15.72M |
| Issuance of Common Stock | 14.84M | 3.38M | 3.38M | 3.47M | 3.47M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.07M | -4.27M | -3.01M | -975.00K | -2.84M |
| Cash from Financing | 15.44M | 3.52M | -251.00K | 2.38M | -1.26M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.95M | -1.59M | 869.00K | 144.00K | -2.98M |